Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
- DOI
- 10.1002/hed.70014
- Published
- 2026 Jan
- Container
- Head & neck
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/hed.70014,
title = {Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.},
author = {Cognetti DM and Curry JM and Johnson J and Kwon M and Su SY and Civantos F and Olazagasti C and Valentino J and Arnold SM and Bell RB and Gibson MK and Mannion K and Van Abel KM and Price KA and Dong H and Thorne AH and Suzuki T and Gillenwater AM},
year = {2026},
journal = {Head \& neck},
doi = {10.1002/hed.70014},
url = {https://doi.org/10.1002/hed.70014}
}RIS
TY - JOUR TI - Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. AU - Cognetti DM AU - Curry JM AU - Johnson J AU - Kwon M AU - Su SY AU - Civantos F AU - Olazagasti C AU - Valentino J AU - Arnold SM AU - Bell RB AU - Gibson MK AU - Mannion K AU - Van Abel KM AU - Price KA AU - Dong H AU - Thorne AH AU - Suzuki T AU - Gillenwater AM PY - 2026 JO - Head & neck DO - 10.1002/hed.70014 UR - https://doi.org/10.1002/hed.70014 ER -
APA
DM, C., JM, C., J, J., M, K., SY, S., F, C., C, O., J, V., SM, A., RB, B., MK, G., K, M., KM, V. A., KA, P., H, D., AH, T., T, S., & AM, G. (2026). Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.. Head & neck. https://doi.org/10.1002/hed.70014
Source records
- pubmed · retrieved 2026-09-26T21:00:22.889Z